CLBAX
Price
$40.05
Change
-$0.05 (-0.12%)
Updated
Sep 18 closing price
Net Assets
284.75B
MIBLX
Price
$15.79
Change
-$0.04 (-0.25%)
Updated
Sep 18 closing price
Net Assets
457.77M
Interact to see
Advertisement

CLBAX vs MIBLX

CLBAX vs MIBLX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. MIBLX commentary
Sep 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Hold and MIBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 285B vs. MIBLX (458M). MIBLX pays higher dividends than CLBAX: MIBLX (2.60) vs CLBAX (1.80). CLBAX was incepted earlier than MIBLX: CLBAX (25 years) vs MIBLX (25 years). MIBLX (1.15) is less costly to investors than CLBAX (0.58). CLBAX is a more actively managed with annual turnover of: 50.00 vs. MIBLX (27.04). CLBAX has a lower initial minimum investment than MIBLX: CLBAX (250) vs MIBLX (1000000). MIBLX annual gain was more profitable for investors over the last year : 6.87 vs. CLBAX (5.93). CLBAX return over 5 years is better than : 32.92 vs. MIBLX (13.56).
CLBAXMIBLXCLBAX / MIBLX
Total Expense Ratio0.581.1252%
Annual Report Gross Expense Ratio0.581.1550%
Fund Existence25 years25 years-
Gain YTD7.9637.515106%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets285B458M62,227%
Annual Yield % from dividends1.802.6069%
Returns for 1 year5.936.8786%
Returns for 3 years41.2639.74104%
Returns for 5 years32.9213.56243%
Returns for 10 years93.6360.54155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRBGX189.491.12
+0.59%
T. Rowe Price Blue Chip Growth R
TSRPX23.36N/A
N/A
Nuveen Quant Small Cap Equity Premier
GABPX56.81-0.15
-0.26%
Goldman Sachs Equity Income P
FDAGX90.63-0.61
-0.67%
Fidelity Advisor Consumer Staples A
RYOIX93.54-1.10
-1.16%
Rydex Biotechnology Inv